Claris News
Most Popular Claris Story
Pfizer nabs generics, emerging-market rights
Pfizer hasn't been standing idly by as its rivals forge ahead into generics and emerging markets. The drugmaker announced today that it has inked licensing deals with two Indian pharma firms--deals... Read more...
Latest Headlines
- January 27, 2010
- November 19, 2009
- May 20, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
